262 related articles for article (PubMed ID: 11136301)
21. Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.
Soeki T; Kitani M; Kusunose K; Yagi S; Taketani Y; Koshiba K; Wakatsuki T; Orino S; Kawano K; Sata M
Hypertens Res; 2012 Nov; 35(11):1058-62. PubMed ID: 22763473
[TBL] [Abstract][Full Text] [Related]
22. Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients.
Minami J; Ishimitsu T; Kawano Y; Matsuoka H
Clin Exp Pharmacol Physiol; 1998; 25(7-8):572-6. PubMed ID: 9673431
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effect of cilnidipine on morning hypertension and white-coat effect in patients with essential hypertension.
Yamagishi T
Hypertens Res; 2006 May; 29(5):339-44. PubMed ID: 16832154
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats.
Hosono M; Hiruma T; Watanabe K; Hayashi Y; Ohnishi H; Takata Y; Kato H
Jpn J Pharmacol; 1995 Oct; 69(2):119-25. PubMed ID: 8569048
[TBL] [Abstract][Full Text] [Related]
25. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
26. Stress-induced blood pressure elevation in subjects with mild cognitive impairment: effects of the dual-type calcium channel blocker, cilnidipine.
Kawashima Y; Akishita M; Hasegawa H; Kozaki K; Toba K
Geriatr Gerontol Int; 2008 Dec; 8(4):278-83. PubMed ID: 19149840
[TBL] [Abstract][Full Text] [Related]
27. Time course for blood pressure lowering of dihydropyridine calcium channel blockers.
Ghamami N; Chiang SH; Dormuth C; Wright JM
Cochrane Database Syst Rev; 2014 Aug; (8):CD010052. PubMed ID: 25173808
[TBL] [Abstract][Full Text] [Related]
28. Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients.
Kario K; Nariyama J; Kido H; Ando S; Takiuchi S; Eguchi K; Niijima Y; Ando T; Noda M
J Clin Hypertens (Greenwich); 2013 Jul; 15(7):465-72. PubMed ID: 23815534
[TBL] [Abstract][Full Text] [Related]
29. Effects of the L/N-type calcium channel antagonist cilnidipine on morning blood pressure control and peripheral edema formation.
Narita S; Yoshioka Y; Ide A; Kadokami T; Momii H; Yoshida M; Ando S
J Am Soc Hypertens; 2011; 5(5):410-6. PubMed ID: 21640687
[TBL] [Abstract][Full Text] [Related]
30. Effect of isradipine on cardiopulmonary baroreflex function, regional blood flow, and vascular responsiveness in hypertensive patients.
Hirsch AT; Dzau VJ; Cutler SS; Levenson DJ; Creager MA
J Cardiovasc Pharmacol; 1992 Feb; 19(2):272-81. PubMed ID: 1376797
[TBL] [Abstract][Full Text] [Related]
31. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
Seino H; Miyaguchi S; Yamazaki T; Ota S; Yabe R; Suzuki S
Arzneimittelforschung; 2007; 57(8):526-31. PubMed ID: 17915639
[TBL] [Abstract][Full Text] [Related]
32. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension.
Minami J; Numabe A; Andoh N; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
Br J Clin Pharmacol; 2004 May; 57(5):632-9. PubMed ID: 15089817
[TBL] [Abstract][Full Text] [Related]
33. Effect of the calcium antagonist benidipine hydrochloride on 24-h ambulatory blood pressure in patients with mild to moderate hypertension in a double-blind study against placebo.
Nakajima O; Akioka H; Miyazaki M
Arzneimittelforschung; 2000 Jul; 50(7):620-5. PubMed ID: 10965418
[TBL] [Abstract][Full Text] [Related]
34. The L/N-type calcium channel blocker, Cilnidipine, reduces heart rate and albuminuria in patients with type 2 diabetes.
Tanaka M
J Int Med Res; 2010; 38(2):602-10. PubMed ID: 20515573
[TBL] [Abstract][Full Text] [Related]
35. The effect of combination therapy with an L/N-Type Ca(2+) channel blocker, cilnidipine, and an angiotensin II receptor blocker on the blood pressure and heart rate in Japanese hypertensive patients: an observational study conducted in Japan.
Nagahama S; Norimatsu T; Maki T; Yasuda M; Tanaka S
Hypertens Res; 2007 Sep; 30(9):815-22. PubMed ID: 18037774
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
37. Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, pranidipine (OPC-13340).
Tominaga M; Tsuchihashi T; Kinoshita H; Kobayashi K; Ohya Y; Abe I; Takata Y; Fujishima M
Int J Clin Pharmacol Ther; 1995 May; 33(5):277-80. PubMed ID: 7655766
[TBL] [Abstract][Full Text] [Related]
38. Lercanidipine vs lacidipine in isolated systolic hypertension.
Millar-Craig M; Shaffu B; Greenough A; Mitchell L; McDonald C
J Hum Hypertens; 2003 Nov; 17(11):799-806. PubMed ID: 14578921
[TBL] [Abstract][Full Text] [Related]
39. Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.
Tsuchihashi T; Ueno M; Tominaga M; Kajioka T; Onaka U; Eto K; Goto K
Clin Exp Hypertens; 2005 Nov; 27(8):583-91. PubMed ID: 16303635
[TBL] [Abstract][Full Text] [Related]
40. The effect of an L/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients.
Ito T; Fujimoto N; Ishikawa E; Dohi K; Fujimoto M; Murata T; Kiyohara M; Takeuchi H; Koyabu S; Nishimura H; Takeuchi T; Ito M
Clin Exp Hypertens; 2019; 41(1):92-99. PubMed ID: 29584458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
